Sorry, you need to enable JavaScript to visit this website.

DAURISMO™ (glasdegib) Overdosage


There is no specific antidote for DAURISMO. Management of DAURISMO overdose should include symptomatic treatment and ECG monitoring.

Glasdegib has been administered in clinical studies up to a dose of 640 mg/day. At the highest dosage, the adverse reactions that were dose limiting were nausea, vomiting, dehydration, hypotension, fatigue, and dizziness.

What's New

No Current Announcements.

Contact Pfizer Medical


Please enter your search term(s) for DAURISMO™